(1) The Clinical Advisory Committee may, with the written approval of the Pricing Authority CEO, establish subcommittees to advise or assist the Clinical Advisory Committee in the performance of its functions.
(2) A subcommittee is to be constituted:
(a) partly by one or more members of the Clinical Advisory Committee; and
(b) partly by one or more other persons.
(3) The Pricing Authority may determine, in relation to a subcommittee established under this section:
(a) the subcommittee's terms of reference; and
(b) the terms and conditions of appointment of the members of the subcommittee; and
(c) the procedures to be followed by the subcommittee.